A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1992
12/01/1992	CA2069667A1 Leukotriene b4 antagonist
12/01/1992	CA2069548A1 Gingerol and gingerdiol derivatives as hypocholesterolemic and antiatherosclerotic agents
12/01/1992	CA2068946A1 Heterocyclic derivatives
12/01/1992	CA2068744A1 Gallium compounds
12/01/1992	CA2043657A1 Method to treat kaposi's sarcoma
12/01/1992	CA1310983C Anesthetic compound and method of preparing
12/01/1992	CA1310974C Alkane and alkene derivatives and their preparation and use
12/01/1992	CA1310973C .beta.-(FLUOROMETHYLENE)-5-HYDROXYTRYPTOPHAN AND DERIVATIVES AS PRODRUGS FOR MAO INHIBITION
12/01/1992	CA1310968C Indole derivatives
12/01/1992	CA1310967C Substituted thiacycloalkeno [3,2-b] pyridines, methods of preparation, compositions and method of use
12/01/1992	CA1310966C Substituted 1-(h-imidazol-4-yl)alkyl-benzamides
12/01/1992	CA1310965C Indolizine derivatives, process for preparing them and the compositions containing them
12/01/1992	CA1310964C Antiviral tetrahydroimidazo[1,4]benzodiazepin-2-ones
12/01/1992	CA1310960C Imidazole derivatives having 5-ht3 receptor antagonist activity
12/01/1992	CA1310959C Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
12/01/1992	CA1310957C 10.beta.-ALKYNYLESTRENE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
12/01/1992	CA1310916C Method for treating or preventing locally periodontal disease
12/01/1992	CA1310911C Essential fatty acid compositions
12/01/1992	CA1310910C Medicament preparations containing etofenamate and dimethyl sulphoxide
12/01/1992	CA1310909C Methods and compositions for protecting the gastrointestinal tract
12/01/1992	CA1310908C Treating agents for renal diseases
12/01/1992	CA1310907C N-imidazolyl derivatives of bicyclic compounds useful in medicine
12/01/1992	CA1310906C Solid drug preparations containing micronized crystals of ebselen
11/1992
11/30/1992	WO1992021660A1 Tricyclic polyhydroxylic tyrosine kinase inhibitors
11/30/1992	WO1992021641A1 Dihydroxyindanone tyrosine kinase inhibitors
11/30/1992	CA2109515A1 Dihydroxyindanone tyrosine kinase inhibitors
11/30/1992	CA2108889A1 Tricyclic polyhydroxylic tyrosine kinase inhibitors
11/30/1992	CA2069764A1 Tetracyclic antibiotics and processes for their preparation
11/30/1992	CA2069520A1 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis
11/30/1992	CA2069469A1 Bicyclic rapamycins
11/30/1992	CA2069468A1 Rapamycin dimers
11/30/1992	CA2068484A1 Pradimicin s antibiotics
11/30/1992	CA2068373A1 Phenoxypenyl derivatives
11/29/1992	CA2069691A1 Antimycotics which contain phenylacetic acid derivatives
11/29/1992	CA2069367A1 Pharmaceutical compositions with immunosuppresive properties
11/29/1992	CA2069162A1 Use of nizatidine to treat reflux esophagitis
11/29/1992	CA2068378A1 Chemical compounds
11/29/1992	CA2068377A1 Chemical compounds
11/28/1992	WO1992021345A1 Composition, method and kit for potentiating antitumor activity and for curing tumor
11/28/1992	CA2069570A1 6-substituted steroid products containing a thioethyl group in position 10; process for preparing the same and intermediate compounds thereof; their use as therapeutic agents and pharmaceutical products containing them
11/26/1992	WO1992020823A1 Backbone modified oligonucleotide analogs
11/26/1992	WO1992020822A1 Backbone modified oligonucleotide analogues
11/26/1992	WO1992020816A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/26/1992	WO1992020749A1 Water-based recording ink
11/26/1992	WO1992020711A2 Lhrh antagonists and intermediate products
11/26/1992	WO1992020709A1 Galanin antagonist
11/26/1992	WO1992020703A1 The use of nucleic acid analogues in diagnostics and analytical procedures
11/26/1992	WO1992020702A1 Peptide nucleic acids
11/26/1992	WO1992020696A1 Processes for the diastereoselective synthesis of nucleosides
11/26/1992	WO1992020687A1 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
11/26/1992	WO1992020681A1 Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use
11/26/1992	WO1992020679A1 Benzofuran derivatives
11/26/1992	WO1992020674A1 1h-imidazol-1-yl-methyl benzofuran derivatives, with the imidazolyl moiety being substituted by a cycloalkyl group
11/26/1992	WO1992020673A1 Antihypotensive benzofuran derivatives with n-linked 1h-imidazolylmethyl-5-carboxamide substituents
11/26/1992	WO1992020669A1 Processes for the diastereoselective synthesis of nucleosides
11/26/1992	WO1992020664A1 A process for preparing 4-isothiazolin-3-one
11/26/1992	WO1992020658A1 Novel heterocyclic carboxylic acids
11/26/1992	WO1992020657A1 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists
11/26/1992	WO1992020655A1 Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives
11/26/1992	WO1992020651A2 N-(heteroaryl)-imidazolyl-alkenoic acids
11/26/1992	WO1992020650A2 Phosphite-borane compounds, and method of making and using the same
11/26/1992	WO1992020646A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them
11/26/1992	WO1992020643A1 Novel bi-aromatic compounds derived from a salicilic pattern, method of preparation and use in human and veterinary medecine and in cosmetics
11/26/1992	WO1992020642A1 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
11/26/1992	WO1992020356A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
11/26/1992	WO1992020351A1 Use of the cation-exchanger resins resonium a and sobisterite for controlling circulatory disorders
11/26/1992	WO1992020350A1 Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
11/26/1992	WO1992020348A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene
11/26/1992	WO1992020347A1 2'-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
11/26/1992	WO1992020345A1 Antiretroviral agent
11/26/1992	WO1992020344A1 Antiviral combinations containing nucleoside analogs
11/26/1992	WO1992020343A1 Suppression of thromboxane levels by percutaneous administration of aspirin
11/26/1992	WO1992020342A1 Novel composition of angiotensin-ii receptor antagonists and calcium channel blockers
11/26/1992	WO1992020341A1 Method and composition for ameliorating the adverse effects of aging
11/26/1992	WO1992020340A1 Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
11/26/1992	WO1992020339A1 Agent suitable for transdermal administration containing ergolin derivatives
11/26/1992	WO1992020338A1 Method for the treatment of glaucoma
11/26/1992	WO1992020337A2 Inhibition of metastasis in patients having cancer with pyridyloxazole-2-ones
11/26/1992	WO1992020335A1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
11/26/1992	WO1992020334A1 Pharmaceutical composition comprising ibuprofen salt
11/26/1992	WO1992020333A1 Use of formoterol for treatment of tissue injury
11/26/1992	WO1992020331A1 Receptor ligands
11/26/1992	WO1992020328A2 Improvements in benzodiazepine treatment by cholinesterase inhibitors
11/26/1992	WO1992020327A1 Treatment of fatigue syndrome with cholinesterase inhibitors
11/26/1992	WO1992020326A1 Multi-layered controlled release formulation
11/26/1992	WO1992020308A1 Application system and method for treating warts
11/26/1992	WO1992020241A1 Nutrient preparation
11/26/1992	WO1992020227A1 Substituted orally effective ion chelators related to deferoxamine
11/26/1992	WO1992017446A3 Pyridazinone acetic acids aldose reductase inhibitors
11/26/1992	WO1992017065A3 Method of inhibiting fibrosis
11/26/1992	WO1992016198A3 Method and products for treating the eye
11/26/1992	WO1992013516A3 Improved antiperspirant formulations
11/26/1992	DE4117507A1 Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten Process for the preparation of n (arrow up) 6 (arrow up) -substituted lysine derivatives
11/26/1992	DE4117186A1 Oligo-2'-desoxynukleotide und ihre verwendung als arzneimittel mit antiviraler wirksamkeit Oligo-2'-deoxynucleotides and their use as medicaments having antiviral efficacy
11/26/1992	DE4116912A1 Mittel zur transdermalen applikation enthaltend ergolin-derivate Means for transdermal administration containing ergoline derivatives
11/26/1992	DE4116889A1 Arzneimittel zur bekaempfung von durchblutungsstoerungen Medications to fight durchblutungsstoerungen
11/26/1992	DE4116782A1 Novel drug compsns. contg. optically pure S- or R-sulpiride - useful for treating psychosis, depression or giddiness, avoids problems associated with admin. of racemic sulpiride
11/26/1992	CA2109829A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene
11/26/1992	CA2109805A1 The use of nucleic acid analogues in diagnostics and analytical procedures
11/26/1992	CA2109702A1 Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use

1 ... 7230 7231 7232 7233 7234 7235 7236 7237 7238 7239 7240 7241 7242 7243 7244 7245 7246 7247 7248 7249 7250 ... 7860